BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Pharm Country

  Novo Nordisk (NJ) Launches GLAM™ (Great Life After Menopause) to Ignite the Conversation on Vaginal Health

  September 9, 2013

   · 

  6 min read
• Business

  Debiopharm and TCG Lifesciences Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm

  September 9, 2013

   · 

  3 min read
• Deals

  Johnson & Johnson Kicks Off $5 Billion Clinical Diagnostics Unit Sale

  September 9, 2013

   · 

  1 min read
• Bio NC

  Sapheon, Inc. Raises $19.8 Million in Series B Preferred Offering; U.S. Pivotal Study Completes Enrollment

  September 9, 2013

   · 

  2 min read
• CeQur SA Closes $27 Million Series B Financing

  September 9, 2013

   · 

  3 min read
• Biotech Bay

  Intuitive Surgical, Inc. Says Robot Surgery Complications Study is “Misleading”

  September 9, 2013

   · 

  1 min read
• Deals

  Theragenics Corporation’s “Go-Shop” Period Expires; No Other Bids in Sight

  September 9, 2013

   · 

  6 min read
• FDA

  Tenaxis Medical, Inc. Receives CE Mark Approval to Expand Indications for Its ArterX® Surgical Sealant

  September 9, 2013

   · 

  2 min read
• FDA

  Keystone Heart’s TriGuard™ Cerebral Protection Device Receives CE Marking

  September 9, 2013

   · 

  3 min read
• Business

  CellCentric Ltd. Selects Sygnature Discovery (Formerly known as Sygnature Chemical Services) for Epigenetic Prostate Cancer Program

  September 9, 2013

   · 

  4 min read